Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX)

73 filings reported holding IMRX - Immuneering Corp - Class A Common Stock, $0.001 par value per share as of Q3 2025.
Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.1M shares of 58.8M outstanding shares and own 44.35% of the company stock.
Largest 10 shareholders include FMR LLC (8.79M shares), Sanofi (2.71M shares), VANGUARD GROUP INC (2.42M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.8M shares), ExodusPoint Capital Management, LP (1.52M shares), Logos Global Management LP (950K shares), CITADEL ADVISORS LLC (943K shares), BlackRock, Inc. (681K shares), Blue Owl Capital Holdings LP (550K shares), and GEODE CAPITAL MANAGEMENT, LLC (514K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.